AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2015
Apr 14, 2015
35323_dirs_2015-04-13_2c690feb-1b08-400f-a002-79d86b9a93b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2015-04-10
Reporting Person: TAEGER LESLIE M (SVP Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-10 | Stock Option (Right to Buy) | $0.17 | A | 40000 | Acquired | 2025-04-10 | Common Stock (40000) | Direct |
Footnotes
F1: 50% to vest 4/10/15 and 50% to vest monthly by 4/10/16
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16